Precigen (PGEN) Gains from Investment Securities (2011 - 2026)
Precigen (PGEN) reported Gains from Investment Securities of $146000.0 for Q1 2026, down 69.2% year-over-year from $474000.0 in Q1 2025, and down 88.79% quarter-over-quarter from $1.3 million in Q2 2025.
Precigen (PGEN) Gains from Investment Securities (2011 - 2026) Analysis & Trends
Precigen (PGEN) has 16 years of Gains from Investment Securities data on file, last reported at $146000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $146000.0, down 69.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 204.84% YoY), and the FY2025 annual result was $1.8 million, changed N/A from the prior year.
- Gains from Investment Securities slipped to $146000.0 in Q1 2026 per PGEN's latest filing, from $1.3 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.3 million in Q2 2025 and troughed at -$105000.0 in Q2 2022.
- A 5-year average of $227125.0 and a median of $2000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities plunged 1400.0% in 2022, then soared 250.0% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at -$2000.0 in 2022, then soared by 250.0% to $3000.0 in 2023, then sank by 66.67% to $1000.0 in 2024, then surged by 130100.0% to $1.3 million in 2025, then plunged by 88.79% to $146000.0 in 2026.
- Business Quant data shows PGEN's Gains from Investment Securities at $146000.0 in Q1 2026, $1.3 million in Q2 2025, and $474000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Precigen | 1.38 Bn | 1.38 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,000.00 |
| Mar 31, 2026 | 146,000.00 |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 474,000.00 |
| Mar 31, 2025 | 474,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Jun 30, 2022 | -105,000.00 |
| Jun 30, 2022 | -105,000.00 |
| Dec 31, 2021 | -150,000.00 |
| Dec 31, 2021 | -150,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Sep 30, 2021 | -5,000.00 |